ATM and breast cancer: It was later recognized that women who are heterozygous for pathogenic loss-of-function variants in ATM have an increased risk for breast cancer, leading ATM to become regarded as a moderate penetrance breast cancer susceptibility gene, conferring a 2.3-fold increased risk for breast cancer compared to the general population (4, 5).